trial
as of 2026-07-01Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry
NCTId NCT06610500
at a glance
Phase — · Completed
Enrollment 20 (actual)
Sponsored by Centre Hospitalier Universitaire de Saint Etienne
Primary completion 2023-09-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
20 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2023-05-16
Primary completion
2023-09-12
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
Investigators
1
Anne-Cécile GALLO BLANDIN, MDPrincipal Investigator
Sites
1 total
Saint-Etienne, France
Facts & assertions
4 sourced
Enrollment
20
Phase
NA
Primary Completion Date
2023-09-12
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
indication
investigator